CRT-25 Young Patients With Acute Myocardial Infarction: How Are They Different?  by Desai, Nirav et al.
10.8% vs. 12.1%, p0.0001). There was no difference in DES use between the groups
(46.7% vs. 42.7% vs. 43.4%, p0.84). Cardiogenic shock on presentation (14.8% vs.
12.8% vs. 4.7%, p0.0001), and in-hospital mortality (7.9% vs. 6.4% vs. 1.8%, p0.001)
were highest in the government-sponsored group followed by private and uninsured
groups.
Conclusion: This study demonstrates that insurance type is associated with significant
differences at baseline (clinical, demographic and procedural characteristics) and hospital
outcomes in patients with AMI with PCI.
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Background: The goal of the study is to investigate baseline risk factors, coronary artery
angiogram results and interventions, and hospital outcomes in young patients with acute
myocardial infarction (less than 45 years vs. older than 45 years of age).
Method: Retrospective analysis of 779 patients treated with PCI for acute myocardial
infarction (AMI) at the Los Angeles County Hospital USC Medical Center and Keck
Medical Center of USC between January 2008 and June 2011. Patients were divided into
2 groups according to age 81 young patients and 698 older patients. Baseline demograph-
ics, clinical characteristics, coronary angiogram results, PCI procedural information and
hospital outcomes were compared.
Results: Young patients ( 45 years old) represented 10.3% (n81) of the total patient
population (779 patients). Younger patients were found to have lower rates of diabetes
(22.2% vs. 35.6%, p-value 0.03), more likely to be males (87.6% vs. 76%, p-value 0.02) and
have higher triglyceride levels (212 mg/dl vs. 153.4 mg/dl, p-value 0.014). Young patients
were less likely to have hypertension (41.8% vs. 66.8%, p-value  0.0001). Both groups
had similar rates of NSTEMI (44.4% vs. 49.7%, p-value 0.37) and STEMI (55.6% vs.
50.3%, p-value 0.37). Single vessel coronary artery disease was more prevalent in the
younger group (71.7% vs. 44.6%, p-value0.001) and had a higher rate of total occlusion
of the infarct-related artery (39.7% vs. 19.1%, p-value 0.003). Rates of percutaneous
coronary artery interventions (97.5% vs. 94%, p-value 0.3) and number coronary artery
stent placement (1.5 vs. 1.8, p-value 0.26) were similar between both groups, while the
younger group had a lower rate of post-intervention acute renal failure (1.4% vs. 9.5%,
p-value 0.02). Length of total hospital stay (4.6 days vs. 6 days, p-value 0.15) and intensive
care unit stay (2.9 days vs. 3.6 days, p-value 0.32) was also similar.
Conclusion: Younger age in patients with AMI is associated with male predom-
inance, higher triglyceride levels, and higher rates of single vessel disease and total
occlusion of the infarct related artery. Younger patients had a lower rate of
post-procedure renal failure, while the remaining post-procedural outcomes and
in-hospital mortality were similar.
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Background: Angiotensin converting enzyme inhibitor (ACEI) or angiotensin
receptor blocker was commonly used in patients who have hypertension and
diabetes. The aim of this study was to evaluate the effect of chronic pretreatment
of ACEI or ARB before development of acute myocardial infraction (AMI) for in
hospital outcome after AMI.
Methods: A total of 1369 diabetic-hypertensive patients (66.710.8 years, male 59.2 %)
with AMI (739 ST segment elevation MI and 630 non-ST segment elevation MI) who
were registered in Korea Acute Myocardial Infarction Registry from Nov. 2005 to Aug
2007. were enrolled. We excluded patients with chronic renal failure and chronic heart
failure. The patients were divided into three groups: the patients with chronic pretreat-
ment of ACEI (group I, n148), the patients with chronic pretreatment of ARB (group
II, n175), and patients without pretreatment of ACEI or ARB (group III, n1046).
The clinical characteristics and in-hospital adverse events (IHAEs) were compared among
the groups.
Results: The baseline clinical characteristics were similar among three groups including
clinical diagnosis, Killip class, laboratory parameters, strategy of treatment and angio-
graphic findings. The group I had the lowest rate of IHAEs among the groups (group I:
9.2% vs. group II: 24.8% vs. group III: 17.6%, p0.010). As compared with the group III,
the group I had significantly lower rate of IHAEs (9.2% vs. 17.6%, p0.003), but group
II had significantly higher rate of IHAEs (24.8% vs. 17.6%, p0.049). In Cox
proportional hazard regression analysis, chronic pretreatment of ACEI (RR: 0.474, 95%
CI 0.234-0.958, p0.037) and ARB (RR: 3.261, 95% CI 1.470-7.234, p0.004) were
associated with IHAEs in diabetic hypertensive patient with AMI.
Conclusion: Chronic pretreatment of ACEI decreases IHAEs but that of ARB
increases IHAEs in diabetic hypertensive patient with AMI.
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Background: Insulin resistance (IR) is an associated with a significant increase in the risk
of coronary artery disease. The serum Apolipoprotein B (Apo B) and Apo B/Apo-I ratio
are important markers of IR in non-diabetic, normoglycemic subjects. We investigated
the role of Apo B and ApoB/Apo A1 ratio in patients with acute Non-ST elevation
myocardial infarction (NSTEMI) with total occlusion (TO) of infarct-related artery
(IRA).
Methods: A total of 280 patients (64.512.7 years, male 70 %) with acute NSTEMI
who were underwent percutaneous coronary intervention were enrolled. We excluded
patients with history of diabetes, or medication of oral hypoglycemics, or hemoglobin A1c
(HbA1c) more than 6.5%. The patients were divided into two groups according to the
finding of IRA (Group I: patients with TO of IRA, n84; Group II: patients with
non-TO of IRA, n196).
Results: The level of troponin I are significantly higher in Group I than in Group II
(83.330.1 vs. 71.633.7 ng/mL, p0.044). Most frequent IRA was left circumflex
artery in Group I (50%) and Group I had more complex vascular lesion compared with
Group II (Type C lesion 64.3% vs. 29.0%, p0.001). The level of Apo B and Apo B/Apo
A1 ratio were significantly higher in Group I than in Group II (108.125.3 vs.
96.325.4, p0.019; 0.870.21 vs. 0.740.22, p0.004, respectively). Group I was
divided into two subgroups according to initial therapeutic strategy. In subgroup analysis,
early invasive treatment group had lower in-hospital adverse events than in early
conservative treatment group (5.7% vs. 10.1%, p0.046). In multivariate analysis, elevated
Apo B/Apo A1 ratio showed high probability of TO of IRA (odd ratio, 3.56; 95% CI,
1.12 to 11.38, p0.031).
Conclusions: The level of Apo B and Apo B/Apo A1 ratio were associated TO of IRA
in patients with acute NSTEMI. The markers may be useful for choice of initial
therapeutic strategy in acute NSTEMI.
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Introduction: Acute myocardial infarction (AMI) complicated by cardiogenic shock
(CS) is associated with high mortality rates. This study aimed to explore the correlates for
mortality in patients presented in CS complicating an AMI who were treated with
primary percutaneous intervention (PPCI) and intra-aortic balloon pump counterpulsa-
tion (IABP).
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